Pharmacogenetic dosing by UGT1A1 genotype as first-line therapy for advanced small-bowel adenocarcinoma: A North Central Cancer Treatment Group (NCCTG) trial.
Robert R. McWilliams
No relevant relationships to disclose
Michelle R. Mahoney
No relevant relationships to disclose
Benjamin T. Marchello
No relevant relationships to disclose
Aminah Jatoi
No relevant relationships to disclose
Keith D. Krewer
No relevant relationships to disclose
Matthew M. Ames
No relevant relationships to disclose
Daniel Jay Schneider
No relevant relationships to disclose
Grant R. Seeger
No relevant relationships to disclose
Rex B. Mowat
No relevant relationships to disclose
Steven R. Alberts
No relevant relationships to disclose
Matthew P. Goetz
No relevant relationships to disclose